Top member reports
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#ASX Announcements FDA approval
stale
Nova Eye pioneered the fastest growing segment in the burgeoning ophthalmic market; canal surgery for glaucoma, and holds over 100 patents in this domain
Nova Eye has invested in developing a next generation product (iTrackTM Advance)
The iTrack advance gained FDA approval of Friday 31 Mar. Shares jumped around 25% initially then pulled back for a 5% gain.
I notice there was some activity on strawman a few years ago. Perhaps some strawfolks are able to comment on these new developments;) With the original device still in use the new design should gain widespread adoption fairly soon and it will be interesting to hear progress on the rollout and uptake
Held SM and IRL